 KeyBanc analyst Thomas Blakey initiated coverage of Nutanix Inc NASDAQ:NTNX with an Overweight rating and a 39 price target, suggesting an upside of 38.74. The recent acceleration, new product cross-sell, and go-to-market partnerships have influenced his above-Street revenue and ACV billings outlook. 